HEMATOLOGY

Latest News

FDA Lifts Clinical Hold on Trial of NX-2127 in B-Cell Malignancies
FDA Lifts Clinical Hold on Trial of NX-2127 in B-Cell Malignancies

March 11th 2024

Following changes to the manufacturing process, the phase 1 study of NX-2127 in B-cell malignancies has been cleared to continue by the FDA.

GemCloBu: A New Conditioning Regimen for Aggressive Lymphomas
GemCloBu: A New Conditioning Regimen for Aggressive Lymphomas

March 9th 2024

Unraveling Communication Challenges in MDS Treatment
Unraveling Communication Challenges in MDS Treatment

March 4th 2024

NCCN Guidelines Add Ropeginterferon Alfa for First-Line Polycythemia Vera
NCCN Guidelines Add Ropeginterferon Alfa for First-Line Polycythemia Vera

February 28th 2024

Acknowledging Different Considerations for Ruxolitinib in Severe GVHD
Acknowledging Different Considerations for Ruxolitinib in Severe GVHD

February 26th 2024

Video Series
Video Interviews

More News